In the latest trading session, Anthem closed at $287.66, marking a -0.19% move from the previous day. This change lagged the S&P 500's 0.22% gain on the day. At the same time, the Dow added 0.15%, and the tech-heavy Nasdaq gained 0.6%.
Prior to today's trading, shares of the health insurer had lost 3.51% over the past month. This has lagged the Medical sector's loss of 0.07% and the S&P 500's gain of 2.39% in that time.
ANTM will be looking to display strength as it nears its next earnings release, which is expected to be April 24, 2019. The company is expected to report EPS of $5.83, up 7.76% from the prior-year quarter. Meanwhile, our latest consensus estimate is calling for revenue of $24.25 billion, up 8.52% from the prior-year quarter.
ANTM's full-year Zacks Consensus Estimates are calling for earnings of $19.15 per share and revenue of $99.98 billion. These results would represent year-over-year changes of +20.52% and +9.45%, respectively.
Any recent changes to analyst estimates for ANTM should also be noted by investors. Recent revisions tend to reflect the latest near-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook.
Our research shows that these estimate changes are directly correlated with near-term stock prices. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has moved 0.13% higher. ANTM is currently sporting a Zacks Rank of #2 (Buy).
Investors should also note ANTM's current valuation metrics, including its Forward P/E ratio of 15.05. For comparison, its industry has an average Forward P/E of 15.03, which means ANTM is trading at a premium to the group.
Investors should also note that ANTM has a PEG ratio of 1.03 right now. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. The Medical - HMOs industry currently had an average PEG ratio of 1.17 as of yesterday's close.
The Medical - HMOs industry is part of the Medical sector. This group has a Zacks Industry Rank of 55, putting it in the top 22% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.
Image: Bigstock
Anthem (ANTM) Stock Sinks As Market Gains: What You Should Know
In the latest trading session, Anthem closed at $287.66, marking a -0.19% move from the previous day. This change lagged the S&P 500's 0.22% gain on the day. At the same time, the Dow added 0.15%, and the tech-heavy Nasdaq gained 0.6%.
Prior to today's trading, shares of the health insurer had lost 3.51% over the past month. This has lagged the Medical sector's loss of 0.07% and the S&P 500's gain of 2.39% in that time.
ANTM will be looking to display strength as it nears its next earnings release, which is expected to be April 24, 2019. The company is expected to report EPS of $5.83, up 7.76% from the prior-year quarter. Meanwhile, our latest consensus estimate is calling for revenue of $24.25 billion, up 8.52% from the prior-year quarter.
ANTM's full-year Zacks Consensus Estimates are calling for earnings of $19.15 per share and revenue of $99.98 billion. These results would represent year-over-year changes of +20.52% and +9.45%, respectively.
Any recent changes to analyst estimates for ANTM should also be noted by investors. Recent revisions tend to reflect the latest near-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook.
Our research shows that these estimate changes are directly correlated with near-term stock prices. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has moved 0.13% higher. ANTM is currently sporting a Zacks Rank of #2 (Buy).
Investors should also note ANTM's current valuation metrics, including its Forward P/E ratio of 15.05. For comparison, its industry has an average Forward P/E of 15.03, which means ANTM is trading at a premium to the group.
Investors should also note that ANTM has a PEG ratio of 1.03 right now. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. The Medical - HMOs industry currently had an average PEG ratio of 1.17 as of yesterday's close.
The Medical - HMOs industry is part of the Medical sector. This group has a Zacks Industry Rank of 55, putting it in the top 22% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.